血阶段与蚊虫叮咬诱导的受控疟疾感染中恶性疟原虫配子体血症与传染性的随机临床试验比较
一项随机开放标签试验比较了24名参与者经感染蚊虫叮咬(MB,n=12)或诱导血阶段疟疾(IBSM,n=12)感染恶性疟原虫3D7株后的配子体动力学与蚊媒传染性。结果表明接种方式显著影响配子体生成,支持IBSM作为传播阻断干预早期临床评估的模型。
要点
- IBSM模型可用于传播阻断干预的早期临床评估。
核心结论
- 接种方式对配子体生成有显著影响,IBSM后配子体承诺更高。
- IBSM模型可作为传播阻断干预早期临床评估的模型。
研究设计与样本
- 随机开放标签试验,24名参与者随机经感染蚊虫叮咬(MB,n=12)或诱导血阶段疟疾(IBSM,n=12)感染恶性疟原虫3D7株。
- 亚 curative 哌喹治疗后评估无性体与配子体动力学,并进行蚊虫喂食实验。
关键数值与推荐
- IBSM组配子体中位峰值密度1304/mL(IQR 308-1607/mL)。
- MB组配子体中位峰值密度14/mL(IQR 10-64/mL)。
临床怎么用
- IBSM模型可用于早期临床评估旨在阻断疟疾传播的干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For malaria elimination efforts, it is important to better understand parasite transmission to mosquitoes and develop models for early-clinical evaluation of transmission-blocking interventions. METHODS: In a randomized open-label trial, 24 participants were infected by bites from Plasmodium falciparum 3D7-infected mosquitoes (mosquito bite [MB]; n = 12) or by induced blood-stage malaria (IBSM) with the same parasite line (n = 12). After subcurative piperaquine treatment, asexual parasite and gametocytes kinetics were assessed, and mosquito feeding experiments were performed. RESULTS: Study procedures were well tolerated. The median peak gametocyte density was 1304/mL (interquartile range, 308-1607/mL) after IBSM, compared with 14/mL (10-64/mL) after MB inoculation (P < .001), despite similar peak asexual parasite densities (P = .48). Peak gametocyte density was correlated with preceding pfap2-g transcripts, indicative of gametocyte commitment (ρ = 0.62; P = .002). Direct feeding assays resulted in mosquito infections from 9 of 12 participants after IBSM versus 0 of 12 after MB inoculation (P < .001). CONCLUSIONS: We observed a striking effect of inoculation method on gametocyte production, suggesting higher gametocyte commitment after IBSM. Our direct comparison of MB and IBSM establishes the controlled human malaria infection transmission model, using intravenous administration of P. falciparum-infected erythrocytes as a model for early-clinical evaluation of interventions that aim to interrupt malaria transmission. CLINICAL TRIAL REGISTRATION: NCT03454048.
引用
- Alkema M, Reuling IJ, de Jong GM, et al. A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite-Induced Controlled Malaria Infection. J Infect Dis. 2021. PMID: 32239171. doi:10.1093/infdis/jiaa157
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。